Literature DB >> 11278095

Simultaneous sternothoracic cardiopulmonary resuscitation: a new method of cardiopulmonary resuscitation.

S O Hwang1, K H Lee, J H Cho, B J Oh, D S Gupta, J P Ornato, S H Lee, J Yoon, K H Choe.   

Abstract

No existing device for cardiopulmonary resuscitation (CPR) is designed to exploit both the "cardiac pump" and the "thoracic pump" effect simultaneously. The purpose of this study was to measure the haemodynamic effect of a new simultaneous sternothoracic cardiopulmonary resuscitation (SST-CPR) device that could compress the sternum and constrict the thoracic cavity simultaneously in a canine cardiac arrest model. After 4 min of ventricular fibrillation, 24 mongrel dogs were randomized to receive standard CPR (n=12) or SST-CPR (n=12). SST-CPR generated a new pattern of the aortic pressure curve presumed to be the result of both sternal compression and thoracic constriction. SST-CPR resulted in significantly higher mean arterial pressure than standard CPR (68.9+/-16.1 vs. 30.5+/-10.0 mmHg, P<0.01). SST-CPR generated higher coronary perfusion pressure than standard CPR (47.0+/-11.4 vs. 17.3+/-8.9 mmHg, P<0.01). End tidal CO(2) tension was also higher during SST-CPR than standard CPR (11.6+/-6.1 vs. 2.17+/-3.3 mmHg, P<0.01). In this preliminary animal model study, simultaneous sternothoracic cardiopulmonary resuscitation generated better haemodynamic effects than standard, closed chest cardiopulmonary resuscitation.

Entities:  

Mesh:

Year:  2001        PMID: 11278095     DOI: 10.1016/s0300-9572(00)00250-1

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  1 in total

1.  Comparison of hemodynamic effects and resuscitation outcomes between automatic simultaneous sterno-thoracic cardiopulmonary resuscitation device and LUCAS in a swine model of cardiac arrest.

Authors:  Kyoung-Chul Cha; Hyung Il Kim; Yong Won Kim; Gyo Jin Ahn; Yoon Seob Kim; Sun Ju Kim; Jun Hyuk Lee; Sung Oh Hwang
Journal:  PLoS One       Date:  2019-08-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.